Development of Covid-19 vaccines: Has the Rubicon been crossed?

Authors

  • Osvaldo F. Teglia Médico Especialista en Clínica Médica y Enfermedades Infecciosas. Profesor Asociado de Enfermedades Infecciosas. Facultad de Ciencias Biomédicas. Universidad Austral. Pilar. Buenos Aires.

Keywords:

COVID-19, vaccines, pandemic, scientific development, health regulation

Abstract

This editorial analyzes the accelerated development of COVID-19 vaccines as a turning point in the history of biomedical research. Using the metaphor of “crossing the Rubicon,” it reviews the speed of the preclinical, clinical, regulatory, and manufacturing processes that enabled vaccines to become available in unprecedented timeframes during a global pandemic.

Downloads

Download data is not yet available.

Published

2026-09-03

How to Cite

Teglia, O. F. (2026) “Development of Covid-19 vaccines: Has the Rubicon been crossed?”, Revista Médica de Rosario, 92(2), pp. 72–76. Available at: https://mail.revistamedicaderosario.org/index.php/rm/article/view/desarrollo-de-vacunas-anti-covid-19-se-cruzo-el-rubicon (Accessed: 4 November 2026).

Similar Articles

1 2 3 4 5 6 7 8 9 > >> 

You may also start an advanced similarity search for this article.